Cargando…

Optical injection of mammalian cells using a microfluidic platform

The use of a focused laser beam to create a sub-micron hole in the plasma membrane of a cell (photoporation), for the selective introduction of membrane impermeable substances (optical injection) including nucleic acids (optical transfection), is a powerful technique most commonly applied to treat s...

Descripción completa

Detalles Bibliográficos
Autores principales: Marchington, Robert F., Arita, Yoshihiko, Tsampoula, Xanthi, Gunn-Moore, Frank J., Dholakia, Kishan
Formato: Texto
Lenguaje:English
Publicado: Optical Society of America 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3017997/
https://www.ncbi.nlm.nih.gov/pubmed/21258487
http://dx.doi.org/10.1364/BOE.1.000527
_version_ 1782196002756755456
author Marchington, Robert F.
Arita, Yoshihiko
Tsampoula, Xanthi
Gunn-Moore, Frank J.
Dholakia, Kishan
author_facet Marchington, Robert F.
Arita, Yoshihiko
Tsampoula, Xanthi
Gunn-Moore, Frank J.
Dholakia, Kishan
author_sort Marchington, Robert F.
collection PubMed
description The use of a focused laser beam to create a sub-micron hole in the plasma membrane of a cell (photoporation), for the selective introduction of membrane impermeable substances (optical injection) including nucleic acids (optical transfection), is a powerful technique most commonly applied to treat single cells. However, particularly for femtosecond photoporation, these studies have been limited to low throughput, small-scale studies, because they require sequential dosing of individual cells. Herein, we describe a microfluidic photoporation system for increased throughput and automated optical injection of cells. Hydrodynamic focusing is employed to direct a flow of single-file cells through a focused femtosecond laser beam for photoporation. Upon traversing the beam, a number of transient pores potentially open across the extracellular membrane, which allows the uptake of the surrounding fluid media into the cytoplasm, also containing the chosen injection agent. The process is entirely automated and a rate of 1 cell/sec could readily be obtained, enabling several thousand cells to be injected per hour using this system. The efficiency of optically injecting propidium iodide into HEK293 mammalian cells was found to be 42 ± 8%, or 28 ± 4% taking into account the requirement of post-injection viability, as tested using Calcein AM. This work now opens the way for combining photoporation with microfluidic analyses, sorting, purification or on-chip cell culture studies.
format Text
id pubmed-3017997
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Optical Society of America
record_format MEDLINE/PubMed
spelling pubmed-30179972011-01-21 Optical injection of mammalian cells using a microfluidic platform Marchington, Robert F. Arita, Yoshihiko Tsampoula, Xanthi Gunn-Moore, Frank J. Dholakia, Kishan Biomed Opt Express Microfluidics The use of a focused laser beam to create a sub-micron hole in the plasma membrane of a cell (photoporation), for the selective introduction of membrane impermeable substances (optical injection) including nucleic acids (optical transfection), is a powerful technique most commonly applied to treat single cells. However, particularly for femtosecond photoporation, these studies have been limited to low throughput, small-scale studies, because they require sequential dosing of individual cells. Herein, we describe a microfluidic photoporation system for increased throughput and automated optical injection of cells. Hydrodynamic focusing is employed to direct a flow of single-file cells through a focused femtosecond laser beam for photoporation. Upon traversing the beam, a number of transient pores potentially open across the extracellular membrane, which allows the uptake of the surrounding fluid media into the cytoplasm, also containing the chosen injection agent. The process is entirely automated and a rate of 1 cell/sec could readily be obtained, enabling several thousand cells to be injected per hour using this system. The efficiency of optically injecting propidium iodide into HEK293 mammalian cells was found to be 42 ± 8%, or 28 ± 4% taking into account the requirement of post-injection viability, as tested using Calcein AM. This work now opens the way for combining photoporation with microfluidic analyses, sorting, purification or on-chip cell culture studies. Optical Society of America 2010-08-09 /pmc/articles/PMC3017997/ /pubmed/21258487 http://dx.doi.org/10.1364/BOE.1.000527 Text en ©2010 Optical Society of America http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 Unported License, which permits download and redistribution, provided that the original work is properly cited. This license restricts the article from being modified or used commercially.
spellingShingle Microfluidics
Marchington, Robert F.
Arita, Yoshihiko
Tsampoula, Xanthi
Gunn-Moore, Frank J.
Dholakia, Kishan
Optical injection of mammalian cells using a microfluidic platform
title Optical injection of mammalian cells using a microfluidic platform
title_full Optical injection of mammalian cells using a microfluidic platform
title_fullStr Optical injection of mammalian cells using a microfluidic platform
title_full_unstemmed Optical injection of mammalian cells using a microfluidic platform
title_short Optical injection of mammalian cells using a microfluidic platform
title_sort optical injection of mammalian cells using a microfluidic platform
topic Microfluidics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3017997/
https://www.ncbi.nlm.nih.gov/pubmed/21258487
http://dx.doi.org/10.1364/BOE.1.000527
work_keys_str_mv AT marchingtonrobertf opticalinjectionofmammaliancellsusingamicrofluidicplatform
AT aritayoshihiko opticalinjectionofmammaliancellsusingamicrofluidicplatform
AT tsampoulaxanthi opticalinjectionofmammaliancellsusingamicrofluidicplatform
AT gunnmoorefrankj opticalinjectionofmammaliancellsusingamicrofluidicplatform
AT dholakiakishan opticalinjectionofmammaliancellsusingamicrofluidicplatform